Skip to main content
. Author manuscript; available in PMC: 2017 Aug 12.
Published in final edited form as: Nature. 2017 Apr 10;545(7652):60–65. doi: 10.1038/nature22079

Extended Data Figure 1. Clinical characteristics, response data, and immune data for cohorts analysed.

Extended Data Figure 1

a, Penn pembro Expanded Access Program (left) and MSKCC Keynote-001 trial (right) that were included in analysis. b, Immune and clinical data from analysed patients in Penn cohort stratified by fold change Ki67 greater or less than 2.2 (blue, responder; red, non-responder).